Xperi Inc. (XPER)
(Delayed Data from NYSE)
$8.82 USD
-0.15 (-1.67%)
Updated Aug 30, 2024 04:00 PM ET
After-Market: $8.84 +0.02 (0.23%) 7:58 PM ET
2-Buy of 5 2
D Value C Growth B Momentum C VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$8.82 USD
-0.15 (-1.67%)
Updated Aug 30, 2024 04:00 PM ET
After-Market: $8.84 +0.02 (0.23%) 7:58 PM ET
2-Buy of 5 2
D Value C Growth B Momentum C VGM
Zacks News
Xperi (XPER) Upgraded to Buy: Here's Why
by Zacks Equity Research
Xperi (XPER) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Wall Street Analysts Think Xperi (XPER) Could Surge 109.73%: Read This Before Placing a Bet
by Zacks Equity Research
The mean of analysts' price targets for Xperi (XPER) points to a 109.7% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
Xperi (XPER) Shows Fast-paced Momentum But Is Still a Bargain Stock
by Zacks Equity Research
Xperi (XPER) could be a great choice for investors looking to buy stocks that have gained strong momentum recently but are still trading at reasonable prices. It is one of the several stocks that made it through our 'Fast-Paced Momentum at a Bargain' screen.
Down -18.64% in 4 Weeks, Here's Why You Should You Buy the Dip in Xperi (XPER)
by Zacks Equity Research
The heavy selling pressure might have exhausted for Xperi (XPER) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.
4 Stocks to Buy as Services Sector Makes Solid Rebound
by Ritujay Ghosh
The services sector has expanded in 46 out of the past 48 months. Stocks like Xperi Inc. (XPER), Booz Allen Hamilton Holding Corporation (BAH), Maplebear Inc. (CART) and HNI Corporation (HNI) are poised to benefit.
Xperi (XPER) to Report Q1 Earnings: What's in the Offing?
by Zacks Equity Research
Xperi's (XPER) first-quarter 2024 revenues are likely to have declined due to weak performances across Pay-TV and the media platform.
CoreCard Corporation (CCRD) Beats Q1 Earnings and Revenue Estimates
by Zacks Equity Research
CoreCard (CCRD) delivered earnings and revenue surprises of 250% and 8.97%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
Xperi (XPER) Stock Dips While Market Gains: Key Facts
by Zacks Equity Research
Xperi (XPER) closed at $9.56 in the latest trading session, marking a -0.52% move from the prior day.
Xperi (XPER) Ascends While Market Falls: Some Facts to Note
by Zacks Equity Research
The latest trading day saw Xperi (XPER) settling at $10.87, representing a +0.74% change from its previous close.
Trane Technologies plc (TT) Hits Fresh High: Is There Still Room to Run?
by Zacks Equity Research
Trane Technologies (TT) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Wall Street Analysts See an 82.29% Upside in Xperi (XPER): Can the Stock Really Move This High?
by Zacks Equity Research
The average of price targets set by Wall Street analysts indicates a potential upside of 82.3% in Xperi (XPER). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
Wall Street Analysts Think Xperi (XPER) Could Surge 96.81%: Read This Before Placing a Bet
by Zacks Equity Research
The average of price targets set by Wall Street analysts indicates a potential upside of 96.8% in Xperi (XPER). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
Here Is Why Bargain Hunters Would Love Fast-paced Mover Xperi (XPER)
by Zacks Equity Research
Xperi (XPER) made it through our 'Fast-Paced Momentum at a Bargain' screen and could be a great choice for investors looking for stocks that have gained strong momentum recently but are still trading at reasonable prices.
Xperi (XPER) Upgraded to Strong Buy: Here's What You Should Know
by Zacks Equity Research
Xperi (XPER) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
Spotify (SPOT) Reports Q4 Loss, Misses Revenue Estimates
by Zacks Equity Research
Spotify (SPOT) delivered earnings and revenue surprises of -387.50% and 0.11%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?
Zacks Value Investor Highlights: Potbelly, Xperi, Virco, Enviri and Anywhere Real Estate
by Zacks Equity Research
Potbelly, Xperi, Virco, Enviri and Anywhere Real Estate have been highlighted in this Value Investor article.
5 Outstanding Small Cap Value Stocks
by Tracey Ryniec
How to screen for top small cap value stocks, which also have growth.
Wall Street Analysts Believe Xperi (XPER) Could Rally 82.28%: Here's is How to Trade
by Zacks Equity Research
The average of price targets set by Wall Street analysts indicates a potential upside of 82.3% in Xperi (XPER). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
Does Xperi (XPER) Have the Potential to Rally 99.71% as Wall Street Analysts Expect?
by Zacks Equity Research
The mean of analysts' price targets for Xperi (XPER) points to a 99.7% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
Wall Street Analysts Predict an 89.63% Upside in Xperi (XPER): Here's What You Should Know
by Zacks Equity Research
The mean of analysts' price targets for Xperi (XPER) points to an 89.6% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
Do Options Traders Know Something About Xperi (XPER) Stock We Don't?
by Zacks Equity Research
Investors need to pay close attention to Xperi (XPER) stock based on the movements in the options market lately.
Xperi (XPER) Tops Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Xperi (XPER) delivered earnings and revenue surprises of 23.81% and 4.67%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Coursera (COUR) Reports Q2 Loss, Misses Revenue Estimates
by Zacks Equity Research
Coursera (COUR) delivered earnings and revenue surprises of -7.14% and 4.35%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Xperi (XPER) Q1 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
Xperi (XPER) delivered earnings and revenue surprises of 46.03% and 6.43%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Telus International (TIXT) Surpasses Q1 Earnings Estimates
by Zacks Equity Research
Telus (TIXT) delivered earnings and revenue surprises of 4% and 0.31%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?